| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | +133.6% |
| R&D Expense | $7.2M | -4.9% |
| SG&A Expense | $4.7M | -11.9% |
| Operating Income | -$6.7M | +37.2% |
| Interest Expense | $9K | -97.5% |
| Net Income | -$8.0M | +24.8% |
| EPS (Basic) | -$11.45 | -144.1% |
| EPS (Diluted) | -$11.45 | -144.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | +211.7% |
| Current Assets | $5.3M | +133.5% |
| Total Assets | $5.6M | +106.7% |
| Current Liabilities | $2.2M | -33.8% |
| Total Liabilities | $2.2M | -34.0% |
| Stockholders' Equity | $3.7M | +1248.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | +30.4% |
| Financing Cash Flow | $9.9M | +12.9% |